Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | BIIB | BNTX | ||
| Company | Alnylam Pharmaceuticals | Biogen Inc | Biontech Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 228.88 | 217.76 | 110.92 | ||
| High | 238.22 | 219.12 | 120.33 | ||
| Low | 228.34 | 215.00 | 110.89 | ||
| Last | 238.17 | 218.11 | 116.33 | ||
| Change | +8.87 | +3.76 | +5.44 | ||
| Percent Change | +3.87% | +1.75% | +4.91% | ||
| Volume | 702,131 | 230,383 | 1,606,858 | ||
| 20-Day Average Volume | 2,326,105 | 938,616 | 1,528,848 | ||
| Previous | 229.30 | 214.35 | 110.89 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 232.42 | 208.69 | 95.46 | ||
| 20-Day Raw Stochastic | 42.94% | 85.32% | 88.70% | ||
| 20-Day Relative Strength | 45.10 | 58.40 | 74.84 | ||
| Weighted Alpha | -46.50 | +55.62 | +10.05 | ||
| Today's Opinion | 88% Sell | 100% Buy | 24% Buy | ||
| Yesterday's Opinion | 100% Sell | 100% Buy | 24% Buy | ||
| Last Month's Opinion | 100% Sell | 80% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.94% since 08/14/26 | +4.28% since 08/14/26 | +25.34% since 08/14/26 | ||
| Low | 222.01 on 08/18/26 | 207.62 on 08/17/26 | 91.01 on 08/18/26 | ||
| High | 244.03 on 08/19/26 | 222.15 on 08/19/26 | 120.31 on 08/21/26 | ||
| 1-Month | |||||
| %Chg | -12.43% since 07/21/26 | +7.70% since 07/21/26 | +26.37% since 07/21/26 | ||
| Low | 197.81 on 07/30/26 | 196.91 on 07/23/26 | 88.20 on 08/04/26 | ||
| High | 290.60 on 07/29/26 | 222.15 on 08/19/26 | 120.31 on 08/21/26 | ||
| 3-Month | |||||
| %Chg | -20.92% since 05/21/26 | +15.49% since 05/21/26 | +28.32% since 05/21/26 | ||
| Low | 197.81 on 07/30/26 | 184.90 on 06/02/26 | 84.96 on 06/09/26 | ||
| High | 380.00 on 07/09/26 | 222.15 on 08/19/26 | 120.31 on 08/21/26 | ||
| 6-Month | |||||
| %Chg | -29.31% since 02/20/26 | +13.95% since 02/20/26 | +5.93% since 02/20/26 | ||
| Low | 197.81 on 07/30/26 | 168.64 on 04/06/26 | 79.52 on 03/10/26 | ||
| High | 380.00 on 07/09/26 | 222.15 on 08/19/26 | 120.31 on 08/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,682,404 | 31,671,068 | 28,042,308 | ||
| Shares Outstanding, K | 133,809 | 147,754 | 252,884 | ||
| Annual Sales, $M | 3,713,940,000 | 9,890,600,000 | 3,247,010,000 | ||
| Annual Net Income, $M | 313,750,000 | 1,292,900,000 | -1,285,380,000 | ||
| Last Qtr Sales, $M | 1,290,950,000 | 2,736,000,000 | 122,780,000 | ||
| Last Qtr Income, $M | 164,490,000 | 97,500,000 | -954,340,000 | ||
| 60-Month Beta | 0.30 | 0.17 | 1.27 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.84 on 07/30/26 | 3.60 on 07/29/26 | -2.58 on 08/04/26 | ||
| Latest Earnings Date | 10/29/26 | 10/29/26 | 11/02/26 | ||
| Most Recent Dividend | N/A | N/A | 3.084 on 06/02/22 | ||
| Next Ex-Dividend Date | N/A | N/A | 06/02/22 | ||
| Ratios | |||||
| Price/Earnings ttm | 45.09 | 15.86 | 0.00 | ||